Merlin Biomed
North America, New York, United States, New York
Description
Network Solutions - Original domain name registration and reservation services with variety of internet-related business offerings.
Investor Profile
Merlin Biomed has backed more than 18 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 12 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series D, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Canada.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series Unknown (33%)
- Series D (28%)
- Series C (17%)
- Series E (11%)
- Series B (6%)
- Post Ipo Equity (6%)
Country Focus
- United States (83%)
- United Kingdom (11%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (6%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Biopharma
- Medical
- Oncology
- Information Technology
- Medical Device
- Developer Tools
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
